中国快讯 (China Crunch) 为中国读者提供及时的加密新闻、市场洞察和监管动态。
China drugmakers race into weight loss market as semaglutide patent expiry opens door to competition
China’s pharmaceutical sector is rapidly moving into the global weight loss drug race after the expiration of Novo Nordisk’s semaglutide patent in the country, unlocking a major commercial opportunity for domestic developers. The shift comes as demand for obesity treatments surges worldwide and